Breast Cancer Flashcards

1
Q

Breast cancer is the most common cancer in women. What is the aprox number of invasive breast cancers in the UK each year?

1 - 60
2 - 600
3 - 6000
4 - 60,000

A

4 - 60,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Breast cancer is the most common cancer in women. What is the aprox number of non-invasive breast cancers in the UK each year?

1 - 80-90
2 - 800-900
3 - 8000-9000
4 - 80,000-90,000

A

3 - 8000-9000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What % of women diagnosed with breast cancer will survive beyond 10 years?

1 - 7.6%
2 - 27.6%
3 - 57.6%
4 - 76%

A

4 - 76%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which of the following is NOT a risk factor for breast cancer?

1 - age (>70)
2 - oestrogen exposure (COC)
3 - obesity
4 - alcohol
5 - hypertension
6 - ethnicity (highest in black women)
7 - higher socioeconomic group
8 - previous hodgkin lymphoma

A

5 - hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

The following are risk factors for breast cancer, but which is the largest risk factor?

1 - age (>70)
2 - oestrogen exposure
3 - obesity
4 - alcohol
5 - ethnicity (highest in black women)
6 - higher socioeconomic group
7 - previous hodgkin lymphoma

A

1 - age (>70)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is it important to know when a woman has menarche (1st period)?

1 - before this women are not at risk of breast cancer
2 - oestrogen exposure is a risk factor for breast cancer
3 - women who have delayed menarche will not develop breast cancer

A

2 - oestrogen exposure is a risk factor for breast cancer

  • late menopause is also a risk as the patient will continue to have more exposure to estrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Breast cancer has a genetic risk associated with it. Which group of patients are at highest risk?

1 - asians
2 - ashkenazi jews
3 - caucasians
4 - muslims

A

2 - ashkenazi jews

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are all neoplasias malignant?

A
  • no
  • can be benign and not invade other tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The range of neoplastic disease ranges from cellular atypia through carcinoma in situ to invasive disease. What is cellular atypia?

1 - cells with abnormal morphology growing rapidly
2 - normal cells growing rapidly
3 - cells growing in size and number
4 - too many cells present

A

1 - cells with abnormal morphology growing rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the most common 2 week referral pathway from GPs?

1 - colon cancer
2 - breast cancer
3 - lung cancer
4 - pancreatic cancer

A

2 - breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Breast cancer is the most common cancer in women. What is the aprox number of invasive breast cancers in the UK each year?

1 - 60
2 - 600
3 - 6000
4 - 60,000

A

4 - 60,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Breast cancer is the most common cancer in women. What is the aprox number of non-invasive breast cancers in the UK each year?

1 - 80-90
2 - 800-900
3 - 8000-9000
4 - 80,000-90,000

A

3 - 8000-9000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What % of women diagnosed with breast cancer will survive beyond 10 years?

1 - 7.6%
2 - 27.6%
3 - 57.6%
4 - 76%

A

4 - 76%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which of the following is NOT a risk factor for breast cancer?

1 - age (>70)
2 - oestrogen exposure
3 - obesity
4 - alcohol
5 - hypertension
6 - ethnicity (highest in black women)
7 - higher socioeconomic group
8 - previous hodgkin lymphoma

A

5 - hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The following are risk factors for breast cancer, but which is the largest risk factor?

1 - age (>70)
2 - oestrogen exposure
3 - obesity
4 - alcohol
5 - ethnicity (highest in black women)
6 - higher socioeconomic group
7 - previous hodgkin lymphoma

A

1 - age (>70)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is it important to know when a woman has menarche (1st period)?

1 - before this women are not at risk of breast cancer
2 - oestrogen exposure is a risk factor for breast cancer
3 - women who have delayed menarche will not develop breast cancer

A

2 - oestrogen exposure is a risk factor for breast cancer

  • late menopause is also a risk as the patient will continue to have more exposure to estrogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Breast cancer has a genetic risk associated with it. Which group of patients are at highest risk?

1 - asians
2 - ashkenazi jews
3 - caucasians
4 - muslims

A

2 - ashkenazi jews

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Are all neoplasias malignant?

A
  • no
  • can be benign and not invade other tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The range of neoplastic disease ranges from cellular atypia through carcinoma in situ to invasive disease. What is cellular atypia?

1 - cells with abnormal morphology growing rapidly
2 - normal cells growing rapidly
3 - cells growing in size and number
4 - too many cells present

A

1 - cells with abnormal morphology growing rapidly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the most common 2 week referral pathway from GPs?

1 - colon cancer
2 - breast cancer
3 - lung cancer
4 - pancreatic cancer

A

2 - breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Patients of a certain age will require a mammogram screening every 3 years at what age?

1 - >40
2 - >50
3 - >60
4 - >70

A

2 - >50
- typically get invited between 50-53 years of age
- stops at age 71

Screening involves 2 X-rays of each breast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

How many breast cancers are detected via the breast cancer screening pathway?

1 - 1:3
2 - 1:10
3 - 1:20
4 - 1:100

A

1 - 1:3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which of the following patients would be referred on a 2-week referral for a breast cancer assessment?

1 - 21 year old with pain in breast
2 - 30 year old with discharge in both nipples
3 - 25 year old with breast lump and pain
4 - 30 years old with breast lump with or without pain

A

4 - 30 years old with breast lump with or without pain

Criteria:
>30 years, unexplained breast lump with/without pain
> 50 years with any of the following symptoms in one nipple:
- Discharge
- Retraction
- Other changes of concern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

The criteria for a 2 week breast assessment referral is:

> 30 years, unexplained breast lump with/without pain
50 years with any of the following symptoms in one nipple:
- Discharge
- Retraction
- Other changes of concern

Is this criteria definitive?

A
  • No

Consider referral in the following:
- skin changes that suggest breast cancer
- >30 with an unexplained lump in the axilla
- non-urgent referralin people aged < 30 years with an unexplained breast lump with or without pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What % of breast lumps in women between 20-50 y/o are benign?

1 - 0.9%
2 - 9%
3 - 49%
4 - >90%

A

4 - >90%

  • patients always think malignancy
  • if lump is present we do triple therapy (CRP)
  • C = Clinical examination and given a ’P’ or ‘E’ code (palpation/examination, respectively)
  • R = Radiographic Imaging assessment and given a ‘M’ code (mammogram) and ‘U’ code (ultrasound)
  • P = Pathophysiological biopsy if appropriate ‘B’ code (biopsy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

In patients with a BRCA1 or 2 mutation they will be screening annually. If they are aged >40 they will receive mammogram. if they are aged 30-49 they will receive what?

1 - ultrasound
2 - X-ray
3 - MRI
4 - PET

A

3 - MRI (most sensitive)
- ultrasound if MRI not possible

  • mammogram not as sensitive on dense tissue (young breasts contain a lot of lobules that appear white on mammogram)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Are all suspected malignancies screened with mammogram detected?

A
  • no
  • of 10,000 screenings 500-700 women are recalled for reassessment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Why is it important to know when a woman has menarche (1st period)?

1 - before this women are not at risk of breast cancer
2 - oestrogen exposure is a risk factor for breast cancer
3 - women who have delayed menarche will not develop breast cancer

A

2 - oestrogen exposure is a risk factor for breast cancer

Early menarche and late menopause increases exposure to oestrogen

Also need to ask about breast feeding (reduces risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

55 year old post-menopausal lady presents to GP with a lump in her left breast. Which of the following are important to ask about in her history?

1 - IUD (copper coil)
2 - IUS 9 progesterone only)
3 - progesterone only pill
4 - combined oral contraceptive pill

A

4 - combined oral contraceptive pill

Increased exposure to oestrogen increases the risk of breast cancer

30
Q

Breast cancer has a genetic risk associated with it. Which group of patients are at highest risk?

1 - asians
2 - ashkenazi jews
3 - caucasians
4 - muslims

A

2 - ashkenazi jews

31
Q

What is neoplasis?

1 - rapid increase in cell number
2 - cells grow in size but not number
3 - cells grow in number, but abnormally and die like other cells
4 - cells grow in number, but abnormally and do not die like other cells

A

4 - cells grow in number, but abnormally and do not die like other cells

32
Q

Are all neoplasias malignant?

A
  • no
  • can be benign and not invade other tissues
33
Q

The range of neoplastic disease ranges from cellular atypia through carcinoma in situ to invasive disease. What is cellular atypia?

1 - cells with abnormal morphology growing rapidly
2 - normal cells growing rapidly
3 - cells growing in size and number
4 - too many cells present

A

1 - cells with abnormal morphology growing rapidly

34
Q

There are a number of genetic risk factors for developing breast cancer. Which of the following is NOT a genetic risk factor for breast cancer?

1 - BRCA1
2 - BRCA2
3 - TP53
4 - HER2
5 - CA19-9

A

5 - CA19-9

  • BRCA1 and BRCA2 can also cause endometrial, ovarian and pancreatic cancer

Only 6% of breast cancer is linked to genetics

35
Q

The breast cancer type 1 and 2 genes (BRCA1 and 2) are tumour suppressor genes. Mutations in these mean tumours will continue to grow unchecked. Are these autosomal dominant or recessive?

A
  • dominant
  • meaning only 1 mutated gene is required to increase risk of cancer
36
Q

The breast cancer type 1 and 2 genes are tumour suppressor genes. Mutations in these mean tumours will continue to grow unchecked. Is BRCA 1 or 2 more common?

A
  • BRCA 1
37
Q

In a patient who is 35, has a breast lump and has risk factors for breast cancer, which is 1st line imaging that should be requested?

1 - Ultrasonography
2 - MRI
3 - Mammogram
4 - CT scan

A

1 - Ultrasonography

Mammogram best in >40
MRI best if implants are present

38
Q

Breast cancer is typically divided into 2 types affecting either ductal epithelium or lobular epithelium. Which is more common?

A
  • ductal epithelium
  • accounts for 85-90%
39
Q

Which of the following defines a stage 2 invasive breast cancer?

1 - poorly differentiated
2 - well differentiated
3 - moderately differentiated

A

3 - moderately differentiated

40
Q

A 55 year old post-menopausal lady presents to GP with a lump in her left breast. She has triple assessment and receives the following score: Left P4, M5,U4

A
41
Q

A 55 year old post-menopausal lady presents to GP with a lump in her left breast. She has triple assessment and is told she has grade III invasive ductal carcinoma. She is also told she has ER8 PR8 HER2+. Is the ER8 PR8 HER2 a good or bad thing?

A
  • Good thing

These can all be targetted specifically in treating the cancer
ER = estrogen receptors
PR = progesterone receptors
HER2 = human epidermal growth factor receptor 2)

42
Q

If a patient has

A
43
Q

In surgery for breast cancer the aim is always to achieve local control. What surgery is generally given for ductal carcinoma in-situ (DCIS)?

1 - mastectomy, axially node biopsy and radiotherapy
2 - wide local excision
3 - wide local excision + radiotherapy
4 - wide local incision + radiotherapy and axillary node biopsy

A

3 - wide local excision + radiotherapy

44
Q

In surgery for breast cancer the aim is always to achieve local control. What surgery is generally given for invasive disease?

1 - mastectomy, axially node biopsy and radiotherapy
2 - wide local excision
3 - wide local excision + radiotherapy
4 - wide local incision + radiotherapy and axillary node biopsy

A

1 - mastectomy, axially node biopsy and radiotherapy

or

4 - wide local incision + radiotherapy and axillary node biopsy

45
Q

Patients with breast surgery can have adjuvant breast radiotherapy, which reduces the risk of reoccurrence following a wide local incision surgery. Is this typically given before or after chemotherapy?

A
  • after chemotherapy
46
Q

A sentinel biopsy can be performed if we are concerned a patients breast cancer has spread. What is the sentinel lymph node?

1 - closest lymph node to tumour
2 - 1st lymph node cancer spreads and has to pass to move to different area
3 - lymph node metastasis are stopped at

A

2 - 1st lymph node cancer spreads and has to pass to move to different area

Axillary lymph nodes drains 85% of the lymphatic drainage from all quadrants of the breast

If sentinel has metastasis then distal lymph nodes need removing

47
Q

In addition to analysing if the biopsy is carcinoma in situ or invasive, we can also look at molecular markers. Which of the following is NOT a common marker looked for in breast biopsy?

1 - human epidermal growth factor receptor 2 (HER-2) receptors
2 - cancer antigen 19-9 (CA19-9) receptors
3 - estrogen receptors
4 - progesterone receptors

A

2 - Cancer antigen 19-9 (CA19-9) receptors
This is a marker for pancreatic cancer

  • if these come back positive then this is good as we can treat with immunotherapy
  • Herceptin is given for HER-2 positive cancers
48
Q

Is the recurrence of breast cancer predictable?

A
  • no
  • can be long term (>5 years)
49
Q

Disease severity and staging determines the 5 year prognosis of a patient with breast cancer.The 5 year survival in stage 1 breast cancer is 98%. What is the 5 year survival for metastatic disease?

1 - 0.25%
2 - 2.5%
3 - 25%
4 - 50%

A

3 - 25%

  • patients normally treated pallatively
50
Q

Which if the following is NOT commonly associated with a poor prognosis in breast cancer?

ER = estrogen receptor
PR = progesterone receptor

1 - high grade cancer/metastatic disease
2 - young age at diagnosis (normally aggressive)
3 - triple positive (HER-2, ER and PR)
4 - axillary lymph node involvement

A

3 - triple positive (HER-2, ER and PR)

  • this is good it means we can treat
  • negative would be bad
51
Q

Tamoxifen is an selective adjuvant hormonal therapy (used to provide a small benefit alongside main treatment) anti-oestrogen drug that competes with oestrogen at the oestrogen receptor on the breast cancer. Which of the following women will this NOT be effective as a treatment in?

1 - 49 y/o postmenopausal woman ER+
2 - 53 y/o postmenopausal woman ER+
3 - 35 y/o pretmenopausal woman ER+
4 - 39 y/o woman ER+

A

4 - 39 y/o woman ER+

Typically only works in women who are pre or postmenopausal

Given for between 5-10 years

52
Q

Tamoxifen is an selective adjuvant hormonal therapy (used to provide a small benefit alongside main treatment) anti-oestrogen drug that competes with oestrogen at the oestrogen receptor on the breast cancer. Which of the following is NOT a common side effect of this medication?

1 - hot flushes
2 - arthralgia
3 - weight loss
4 - mood changes

A

3 - weight loss

53
Q

Tamoxifen is an selective adjuvant hormonal therapy (used to provide a small benefit alongside main treatment) anti-oestrogen drug that competes with oestrogen at the oestrogen receptor on the breast cancer. Tamoxifen can increase the risk of some conditions, which one of the following does NOT have an increased risk when taking Tamoxifen?

1 - vaginal discharge
2 - VTE
3 - cervical cancer
4 - endometrial cancer

A

3 - cervical cancer

54
Q

Aromatase inhibitors are another medication that is used as an adjuvant to the main breast cancer treatment. These drugs work by blocking peripheral conversion of estrogen only. Which group of patients would benefit most from this group of drugs?

1 - pre-menopausal
2 - perimenopausal
3 - postmenopausal
4 - patient preference

A

3 - postmenopausal

Aromatase is an enzyme that converts androgens into estrogen. This is where the majority of oestrogen comes from in post-menopausal women

Given for 5-10 years

55
Q

Aromatase inhibitors are another medication that is used as an adjuvant to the main breast cancer treatment. These drugs work by blocking peripheral conversion of estrogen from aromatase and are used in postmenopausal women as this is where oestrogen comes from. Is this more of less affective in post-menopasual women compared to tamoxifen?

A
  • more effective

15% reduction in breast cancer mortality

56
Q

Aromatase inhibitors are another medication that is used as an adjuvant to the main breast cancer treatment. These drugs work by blocking peripheral conversion of estrogen from aromatase and are used in postmenopausal women as this is where oestrogen comes from. Which of the following is NOT a common side effect of this medication?

1 - osteoporosis
2 - arthralgia
3 - weight gain

A

3 - weight gain

Patients should be given DEXA scans at baseline

57
Q

Trastuzumab (Herceptin HER2+ patients) is a monoclonal antibody that binds to HER2 receptors and inhibit tumour growth. How is this medication given?

1 - chemotherapy
2 - oral
3 - SC
4 - IM

A

3 - SC

Given subcutaneously every 3 weeks for 6-12 months

58
Q

Trastuzumab (Herceptin HER2+ patients) is a monoclonal antibody that binds to HER2 receptors and inhibit tumour growth. Is this given before, after or during breast cancer chemotherapy?

A
  • during for 3-4 months
59
Q

Although there are no side effects of trastuzumab (Herceptin HER2+ patients), which of the following must be monitored?

1 - renal function
2 - liver function
3 - cardiac function
4 - lung function

A

3 - cardiac function

Has been associated with increased risk of changes in LVEF

60
Q

In addition to hormonal and immunotherapy, which 2 of the following medications are also given to patients being treated for breast cancer?

1 - zoledronic acid
2 - amilodopine
3 - levothyroxine
4 - ibandronic acid

A

1 - zoledronic acid
Inhibits osteoclast function and prevents bone resorption.

4 - ibandronic acid
Binds to and adsorbs onto the surface of hydroxyapatite crystals in the bone matrix, thereby preventing osteoclast resorption

61
Q

In addition to hormonal and immunotherapy zoledronic and ibandronic acid are also given. Typically these are given for 3 years. Which of the following is NOT a side effect of zoledronic acid?

1 - jaw osteonecrosis
2 - renal toxicity
3 - GI toxicity
4 - all of the above

A

3 - GI toxicity

This is a side effect of Ibandronic acid

Renal function needs to be monitored in Zolendronic acid

62
Q

In addition to hormonal and immunotherapy zoledronic and ibandronic acid are also given. Typically these are given for 3 years. Which of the following is NOT a side effect of ibandronic acid?

1 - jaw osteonecrosis
2 - renal toxicity
3 - GI toxicity
4 - all of the above

A

2 - renal toxicity

63
Q

In addition to hormonal and immunotherapy zoledronic and ibandronic acid are also given. Typically these are given for 3 years. Which 2 of the following are given alongside these drugs?

1 - vitamin A
2 - vitamin D
3 - calcium
4 - iron

A

2 - vitamin D
3 - calcium

64
Q

The 55 year old post-menopausal lady who had a feft breast pT1pN0M0 Grade III IDC ER8 PR8 Her2+. She is treated with wide local excision and sentinel lymph node biopsy, followed by adjuvant chemotherapy and radiotherapy. She is also given adjuvant bisphosphonatesm herceptin for 1 year and adjuvant letrozole (aromatase inhibitor) for at least 5 years and she then goes onto follow up. The women presents back to A+E 3 years later with worsening headaches, confusion, nausea and vomiting. Which of the following should be arranged as soon as possible?

1 - mammogram
2 - abdominal ultrasound
3 - head CT
4 - none of the above

A

3 - head CT

Headaches, confusion, nausea and vomiting can all be caused by a space occupying lesion in the brain

Image shows mass with surrounding oedema and some midline shift

64
Q

What medication can be given to reduce the swelling in the brain in the case of a space occupying lesion?

1 - dexamethasone
2 - donepezil
3 - memantine
4 - any of the above

A

1 - dexamethasone

ALWAYS GIVE IN MORNINGS AND LUNCHTIME!

Can affect sleep
Prescribe PPI alongside

65
Q

Systemic treatment for metastatic breast cancer can include hormone therapy, HER2 positive therapy or triple negative therapy. Of these which has the overall worst survival rates?

1 - hormone therapy
2 - HER2 positive therapy
3 - triple negative therapy

A

3 - triple negative therapy
Typical survival is 2 years

Hormone therapy = 2-8 years
HER2 positive therapy = 2.5-10 years

66
Q

In systemic treatment for metastatic breast cancer, alongside hormonal and HER2 therapy, which 2 of the following should be given if bone metastasis are detected?

1 - zoledronic acid
2 - amilodopine
3 - levothyroxine
4 - denosumab

A

1 - zoledronic acid
4 - denosumab

67
Q

Inflammatory breast cancer is rare but can occur. Does this have an insidious or rapid onset?

A
  • rapid
    Typically, weeks instead of months
68
Q

Which of the following would increase your concern that a patient has Inflammatory breast cancer and not mastitis, which can present in a similar manner?

1 - breast pain
2 - rapidly growing breast lump
3 - enlarged breast or itching
4 - peau d’orange
5 - all of the above

A

5 - all of the above

This is normally mistaken for mastitis and antibiotics are given, but there is no response.

69
Q

Which of the following is NOT a typical location for metastasis in breast cancer

1 - brain
2 - lung
3 - lymph nodes
4 - liver
5 - bone
6 - colon

A

6 - colon

70
Q

If a patient develops neutropenic sepsis due to the cancer treatment, in addition to initiating the sepsis 6, what can be given in an attempt to increase the neutrophil count?

1 -dexamethasone
2 - granulocyte colony stimulating factors (GCSF)
3 - blood transfusion
4 - frozen WBCs

A

2 - granulocyte colony stimulating factors (GCSF)